Your browser doesn't support javascript.
loading
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.
Guo, Long-Hua; Zhang, Ming-Feng; Zhang, He-Long; Zhou, Jian-Ying; Cai, Xiao-Hong; Long, Yu; Guo, Qi-Sen; Yang, Nong; Zhao, Jun; Xie, Zhan-Hong; Jiang, Bo; Zhu, Ying; Fan, Yun; Xie, Cong-Ying; Hu, Yi; Yao, Yu; Jia, Jun; Li, Xiao-Ling; Cui, Jiu-Wei; Sui, Xi-Zhao; Lin, Wen; Cheng, Ying; Wang, Hui-Juan; Wang, Chang-Li; Zhao, Ming-Fang; Qiao, Gui-Bin; Peng, Li-Jun; Yang, Lin; Chen, Gong-Yan; Cai, Kai-Can; Xu, Xin-Hua; Zhang, Liang-Ming; Feng, Guo-Sheng; Zhou, Jing-Min; Wu, Guo-Wu; Dong, Xiao-Rong; Wang, Li-Feng; Zhang, Hong-Mei; Gao, Ya-Jie; Jiang, Qiu-Ying; Cang, Shun-Dong; Yang, Zhi-Xiong; Song, Xia; Liu, Xiao-Qing; Zhu, Bo; Chen, Feng-Xia; Hu, Chun-Hong; Chen, Xi; Wu, Yi-Long; Zhou, Qing.
Afiliación
  • Guo LH; Department of Medical Oncology, Cancer Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-Sen University, Meizhou, China.
  • Zhang MF; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang HL; Department of Oncology, The Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China.
  • Zhou JY; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Cai XH; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Long Y; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Guo QS; Internal Medicine (Respiratory) of Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shangdong Academy of Medical Sciences, Shangdong Cancer Hospital and Institute, Jinan, China.
  • Yang N; Lung Cancer and Gastrointestinal Unit, Department of Medical Oncology, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
  • Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Xie ZH; Respiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Jiang B; Department of Cadre Medical Oncology, No.3 Hospital Affiliated to Kunming Medical College (Yunnan Tumor Hospital), Kunming, China.
  • Zhu Y; Department of Cadre Medical Oncology, No.3 Hospital Affiliated to Kunming Medical College (Yunnan Tumor Hospital), Kunming, China.
  • Fan Y; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Xie CY; Department of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Hu Y; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
  • Yao Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Jia J; Department of Oncology, Dongguan People's Hospital, Dongguan, China.
  • Li XL; Department of Thoracic Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Cui JW; Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Sui XZ; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
  • Lin W; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • Cheng Y; Department of Medical Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
  • Wang HJ; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China.
  • Wang CL; Department of Lung Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Zhao MF; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
  • Qiao GB; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Peng LJ; Department of Thoracic Surgery, General Hospital of Southern Theater Command, PLA, Guangzhou, China.
  • Yang L; Department of Thoracic Surgery, Shenzhen People's Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen, China.
  • Chen GY; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Cai KC; Department of Thoracic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.
  • Xu XH; Oncology Department, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
  • Zhang LM; Department of Medical Oncology, Yantai Yuhuangding Hospital, Yantai, China.
  • Feng GS; Chemotherapy Section One, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Zhou JM; Department of Respiratory and Critical Care, Tianjin Chest Hospital, Tianjin, China.
  • Wu GW; Department of Medical Oncology, Cancer Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-Sen University, Meizhou, China.
  • Dong XR; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang LF; Oncology Department, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Zhang HM; Department of Clinical Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
  • Gao YJ; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Jiang QY; Department of Oncology, The Second Hospital Affiliated to Harbin Medical University, Harbin, China.
  • Cang SD; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, China.
  • Yang ZX; Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Song X; Department of Respiratory Medicine, Shanxi Provincial Cancer Hospital, Taiyuan, China.
  • Liu XQ; Department of Pulmonary Oncology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.
  • Zhu B; Institute of Cancer, Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
  • Chen FX; Thoracic Surgery, Hainan General Hospital, Haikou, China.
  • Hu CH; Cancer Center, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Chen X; Department of Oncology, The 900th Hospital of the People's Liberation Army Joint Service Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Front Oncol ; 10: 1568, 2020.
Article en En | MEDLINE | ID: mdl-33042801

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China